Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To determine if women can understand the instructions, carry out the test, and interpret the test results. Women will be recruited to complete a test instruction and comprehension assessment and a usability assessment.
To determine if women can understand the instructions, carry out the test, and interpret the test results. Women will be recruited to complete a test instruction and comprehension assessment and a usability assessment. Study participants will be a convenience sample of women seeking health services. Participants will first be asked to review the instructions for the Congo Red Dot Test and complete a short written questionnaire that assesses their comprehension of the test instructions. Participants will then be asked to perform the test using a test control and to interpret the results obtained by answering a second written questionnaire. After the woman performs the test, a healthcare provider will use a matched control to perform a second test.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Women | Women seeking health services will perform the Congo Red Dot test (GV-005) individually by following the the test instructions |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Congo Red Test (GV-005) | Device | The GV-005 is a simple test has been developed to detect unfolded or misfolded proteins in urine. |
|
| Measure | Description | Time Frame |
|---|---|---|
| CRD Test Comprehension | proportion of women who demonstrated various levels of understanding of the instructions for the CRD Test | within 5 minutes of reading test instructions |
| Measure | Description | Time Frame |
|---|---|---|
| CRD Test Usability | the proportion of women able to correctly use the CRD test | within 5 minutes of performing test |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Women attending Centre de Salud Beatriz Velasco de Aleman for health services
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Beverly Winikoff, Dr | Gynuity Health Projects | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Centro de Slaud Beatriz Velasco de Aleman | Mexico City | Mexico |
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Aug 20, 2019 | |
| Reset | Sep 19, 2019 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Aug 20, 2019 | Sep 19, 2019 |
| ID | Term |
|---|---|
| D011225 | Pre-Eclampsia |
| ID | Term |
|---|---|
| D046110 | Hypertension, Pregnancy-Induced |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
urine samples collected